Ci Investments Inc. Ironwood Pharmaceuticals Inc Transaction History

Ci Investments Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$10.86 - $13.95 $612,037 - $786,180	-56,357 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $671,775 - $784,489	56,357 New	56,357 $736,000
Q1 2020 Aug 07, 2020	SELL	$8.58 - $14.01 $371,411 - $606,464	-43,288 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$8.22 - $14.0 $355,827 - $606,032	43,288 New	43,288 $576,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.